Related Experiment Video
Updated: Jun 6, 2025

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
Clinical Management of a Rare Hereditary Bleeding Disorder in an Adult: Glanzmann Thrombasthenia
Reya Mecca1, N Senthil1, Suja Lakshmanan1
1Internal Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder affecting the megakaryocyte lineage and is associated mainly with mucocutaneous bleeding. We herein report a woman in her early 40s, with no known comorbidities, who presented with severe gingival bleeding and severe fatigue. Past history revealed recurrent gingival bleeding, bruising, and heavy menstrual bleeding. Platelet aggregation studies revealed normal aggregation. Finally, a diagnosis of GT with microcytic hypochromic anemia was established after ruling out all the other differential diagnoses. The patient was transfused with multiple units of packed cells (PCs), random donor platelets (RDPs), and single donor platelets (SDPs) and treated with intravenous (IV) and topical tranexamic acid. Our patient presented with a rare bleeding disorder very late in life. GT can be potentially life-threatening and is difficult to diagnose in the early stages. Therefore, it is imperative to highlight the importance of early diagnosis of this rare condition to provide supportive care for a good prognosis.
Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder affecting the megakaryocyte lineage and is associated mainly with mucocutaneous bleeding. We herein report a woman in her early 40s, with no known comorbidities, who presented with severe gingival bleeding and severe fatigue. Past history revealed recurrent gingival bleeding, bruising, and heavy menstrual bleeding. Platelet aggregation studies revealed normal aggregation. Finally, a diagnosis of GT with microcytic hypochromic anemia was established after ruling out all the other differential diagnoses. The patient was transfused with multiple units of packed cells (PCs), random donor platelets (RDPs), and single donor platelets (SDPs) and treated with intravenous (IV) and topical tranexamic acid. Our patient presented with a rare bleeding disorder very late in life. GT can be potentially life-threatening and is difficult to diagnose in the early stages. Therefore, it is imperative to highlight the importance of early diagnosis of this rare condition to provide supportive care for a good prognosis.
More Related Videos
10:39Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Endocarditis III: Medical Management
Mitral Regurgitation III: Medical Management
Myocarditis III: Medical Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins